Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I wonder if acthar generic is progressing better than expected
wonder if there is a influx cash to justify such a position
a lot of available positions
http://www.anipharmaceuticals.com/careers_positions.php
also from the conference call
Annual free cash flow in 2017 is expected to be in the range of $29 million to $34 million reflecting the projected cash flow from operations of $40 million to $45 million and capital expense requirements of nearly $11 million as we continue to invest in our capabilities. Given our rapidly expanding business, anticipated cash flow and relatively low leverage, we believe that we have access to additional sources of liquidity to fund potential future transactions and enhance the growth of our business.
.... later on
Secondly, I think you know that we have a potentially significant transformational asset in corticotrophin, an asset that potentially could drive anywhere from upwards of $200 million of annualized free cash flow for the company.
I wonder how they will grow the company with that kind of money
nice movement after hours
thanks jtfm
would they announce without patent approval?
yes we do , but the name just the facts maam reminds me of the copper clapper caper
global mentioned 3 times in that article
good find,
The Molecular Biologist position will work closely with contract manufacturing labs to create, execute and support the transfer and development of analytical methods for the quantitation of protein/peptide biologic drug substances and drug products.
protein peptide is biosimilars ?
open position
http://www.anipharmaceuticals.com/careers_positions.php#anchor66
Molecular Biologist with no work location... to work with contract manufacturer.... for generic acthar or something else?
Molecular Biologist
The Molecular Biologist position will work closely with contract manufacturing labs to create, execute and support the transfer and development of analytical methods for the quantitation of protein/peptide biologic drug substances and drug products.
Position Responsibilities: Provide technical expertise and experience to coordinate, design and carry out research projects involving the development of ELISA, potency and cell-based molecular biological analytical methods.
Collaborate exclusively with Research Scientists and Associates of several contract manufacturing labs on multiple projects, while taking personal responsibility for success of assigned tasks and projects.
Position Requirements: - Ph.D. in molecular or cellular biology, or biochemistry, with 3+ years of relevant post graduate experience, preferably in industry experience in ELISA development.
- Masters in molecular or cellular biology, or biochemistry with 10+ years of relevant experience.
- Proven expertise in the design and hands-on experience with conducting the development of ELISA assays.
- Experience with cell biology and/or molecular biology experiments is a must (e.g. qPCR, ELISA, Western blotting, SDS-PAGE, etc.)
- Ability to coordinate multiple projects in a fast paced environment.
- Demonstrated ability to perform in a team environment.
- Excellent communication skills
- Excellent organizational and follow-through skills
- Interpersonal skills
- Troubleshooting ability
- Experience with HPLC, bioinformatics and proteomics.
- Ability to plan, organize, implement, and product transfer projects, plans and objectives
- Demonstrated leadership skills
- Previous pharmaceutical industry experience
they announced approval of Oxcarbazepine Tablets
http://www.anipharmaceuticals.com/aboutus_newsmedia_view.php?i=115
have they ever announced a launch ?
also if I remember right wasn't there 25 million set aside for share buy back.... wouldn't this help in any dilution?
thanks catty
catty, im sorry i dont if you find something out please post i know 2 people with ALS ... one just 47 years old
I think another teva basket is in the works too
imho
hanging in there too
what intrigues me is the unmet need for Corticotropin
Large and growing U.S. market with concentrated prescriber base
H.P. Acthar ® gel - $1 billion in annual sales with double digit script growth*
Broad label with minimal penetration
– Use focused in Neurology, Rheumatology, Nephrology and Pulmonology
– Large potential U.S. patient population ~ 4,000,000*
– Small current patient user base ~ 10,000*
all of you seem to be from the north east, country boy here from
the Ozarks
if you have never been here you might enjoy my brother's website
http://ozarklight.com/
its just my opinion but the p/e is absurdly low for a robustly growing company, p/e between 20 to 30 wouldn't be out of line
so if this pans out the stock should be 100-150 by years end imho
so blackrock owns 882289 shares or 7.7 % of the company now?
my son back packed through Europe a couple years ago , he told me one his favorite part of Ireland was the wicklow mountains , hope you were able to see them
- Assets will be acquired by foreign subsidiary to achieve more favorable tax treatment for ANI
if you want to have a look here it is
http://video.cnbc.com/gallery/?video=3000391532
so a deal in the works ,
maybe having to do with getting teva's womens health they are divesting
or a deal like this for contract manufacturing
http://www.outsourcing-pharma.com/Contract-Manufacturing/Halo-seeks-renewal-as-controlled-substance-producer-buys-Teva-plant
since teva is divesting some of its manufacturing
when / where did he say this?
so this is basically a loan based on the future price of the stock, payable with the issuance of stock , anyone care to guess what the price of the stock will be in 5 years ?
Wilmington DE to N Wales PA 45 miles... just sayin
which patent are you referring to?
wilmington delaware office ?
http://www.anipharmaceuticals.com/careers_positions.php
so is text book hippie man history?
does anyone know the timeline for bringing the teva product to market?
if memory serves the oct 2013 corporate presentation mentioned libigel , not mentioned here
http://www.anipharmaceuticals.com/presentations/ANI%20Corporate%20Presentation_March%202014.pdf